SedaLin By XYMOGEN Overview & Drug Interactions
Check For Interactions With SedaLin
Supplement: SedaLin by XYMOGEN
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Seditol
Ingredient Group | Proprietary Blend (Herb/Botanical) |
---|---|
Category | blend |
- Magnolia officinalis
- Ziziphus spinosa
Drugs that interact with SedaLin by XYMOGEN
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with SedaLin. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
2 Capsule(s)
|
Servings per container | 30 |
UPC/BARCODE | 871149001070 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Seditol |
730 mg
|
Proprietary Blend (Herb/Botanical) |
--
|
Other Ingredients: |
HPMC
Microcrystalline Cellulose
Magnesium Stearate
Stearic Acid
Calcium Silicate
Silica
|
---|
Label Statments:
General Statements |
- Scan to learn more!
- Professional use only
- To achieve maximum effectiveness, this non-addictive formula should be taken for a minimum of seven nights in a row and may be taken indefinitely.*
- Sleep Support*
- Exclusive professional formulas
|
---|---|
Seals/Symbols |
- VEGETARIAN CAPS
- SEDITOL(R)
- THIRD-PARTY VERIFIED GMP COMPLIANT
- This package is completely recyclable
- ePV
|
Brand IP Statement(s) |
- Seditol(R) is a registered trademark of NPI, LLc.
U.S. Patent No. US 6,814,987
- (C)2014 XYMOGEN
|
General |
- ZLB-SEDA-04 REV. 102714
|
Suggested/Recommended/Usage/Directions |
- Directions: Take one to two capsules before bedtime, or as directed by your healthcare practitioner.
|
Precautions |
- Consult your healthcare practitioner prior to use.
- Do not take if pregnant or lactating. Do not take if currently taking any prescription medication or receiving medical treatment without consulting your physician.
- Keep out of reach of children.
- Do not use if tamper seal is damaged.
- Storage: Keep closed in a cool, dry place out of reach of children.
|
Formula |
- SedaLin(TM) is an all-natural herbal blend of Magnolia officinalis and Ziziphus spinosa formulated to support restful sleep.
|
FDA Disclaimer Statement |
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Storage |
- Storage: Keep closed in a cool, dry place out of reach of children.
|
Formulation |
- Does not contain: Wheat, gluten, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically-modified organisms (GMO) artificial colors, artificial sweeteners, or preservatives.
|
FDA Statement of Identity |
- Dietary Supplement
|
Brand Information
See all products by this brand
Manufacturer | |
---|---|
Name | XYMOGEN Exclusive Professional Formulas |
Street Address | 6900 Kingspointe Pkwy. |
City | Orlando |
State | FL |
ZipCode | 32819 |
Phone Number | 800-647-6100 |
Web Address | www.xymogen.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.